Member Publications

Liver Center Member Publications

Member publications appearing in PubMed September 2018 *

_______________________________
* Liver-related publications only

Bashir MR, Wolfson T, Gamst AC, Fowler KJ, Ohliger M, Shah SN, Alazraki A, Trout AT, Behling C, Allende DS, Loomba R, Sanyal A, Schwimmer J, Lavine JE, Shen W, Tonascia J, Van Natta ML, Mamidipalli A, Hooker J, Kowdley KV, Middleton MS, Sirlin CB; NASH Clinical Research Network (NASH CRN). Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease. J Magn Reson Imaging. 2018 Oct 14. doi: 10.1002/jmri.26312. [Epub ahead of print] PubMed

Bayrer JR, Wang H, Nattiv R, Suzawa M, Escusa HS, Fletterick RJ, Klein OD, Moore DD, Ingraham HA. LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival. Nat Commun. 2018 Oct 10;9(1):4055. doi: 10.1038/s41467-018-06137-w. PubMed

Breskin A, Westreich D, Cole SR, Hudgens MG, Hurt CB, Seaberg EC, Thio CL, Tien PC, Adimora AA. The Effects of Hepatitis C Infection and Treatment on All-cause Mortality Among People Living With Human Immunodeficiency Virus. Clin Infect Dis. 2018 Oct 12. doi: 10.1093/cid/ciy588. [Epub ahead of print]  PubMed

Ge J, Hsu EK, Bucuvalas J, Lai JC. Deceased Pediatric Donor Livers: How Current Policy Drives Allocation and Transplantation. Hepatology. 2018 Oct 3. doi: 10.1002/hep.30295. [Epub ahead of print] PubMed

Khalili M, Wong RJ. Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net. Dig Dis Sci. 2018 Oct 11. doi: 10.1007/s10620-018-5316-9. [Epub ahead of print] PubMed

Kusumoto S, Arcaini L, Hong X, Jin J, Kim WS, Kwong YL, Peters MG, Tanaka Y, Zelenetz AD, Kuriki H, Fingerle-Rowson G, Nielsen T, Ueda E, Piper-Lepoutre H, Sellam G, Tobinai K. Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy. Blood. 2018 Oct 19. pii: blood-2018-04-848044. doi: 10.1182/blood-2018-04-848044. [Epub ahead of print] PubMed

Kutyavin VI, Chawla A. Aster: A New Star in Cholesterol Trafficking. Cell. 2018 Oct 4;175(2):307-309. doi: 10.1016/j.cell.2018.09.025. PubMed

Kwong AJ, Terrault NA. Use of hepatitis C viraemic organs in kidney transplantation: a need to hit the pause button? Nat Rev Gastroenterol Hepatol. 2018 Oct 17. doi: 10.1038/s41575-018-0071-0. [Epub ahead of print] PubMed

Liu X, Song X, Zhang J, Xu Z, Che L, Qiao Y, Ortiz Pedraza Y, Cigliano A, Pascale RM, Calvisi DF, Liu Y, Chen X. Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma. Cancer Med. 2018  Oct 28. doi: 10.1002/cam4.1777. [Epub ahead of print] PubMed

Rosenthal P, Ling SC, Belle SH, Murray KF, Rodriguez-Baez N, Schwarzenberg SJ, Teckman J, Lin HS, Schwarz KB; Hepatitis B Research Network (HBRN). Combination of entecavir/ peginterferon alfa-2a in children with HBeAg-positive immune tolerant chronic hepatitis B virus infection. Hepatology. 2018 Oct 15. doi: 10.1002/hep.30312. [Epub ahead of print] PubMed

Sarkar M, Lai JC, Sawinski D, Zeigler TE, Cedars M, Forde KA. Sex Hormone Levels by Presence and Severity of Cirrhosis in Women With Chronic Hepatitis C Virus (HCV) Infection. J Viral Hepat. 2018 Oct 19. doi: 10.1111/jvh.13027. [Epub ahead of print] PubMed

Takasaka N, Seed RI, Cormier A, Bondesson AJ, Lou J, Elattma A, Ito S, Yanagisawa H, Hashimoto M, Ma R, Levine MD, Publicover J, Potts R, Jespersen JM, Campbell MG, Conrad F, Marks JD, Cheng Y, Baron JL, Nishimura SL. Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells. JCI Insight. 2018 Oct 18;3(20). pii: 122591. doi: 10.1172/jci.insight.122591. [Epub ahead of print] PubMed